PubRank

Allen E Thornton

Author PubWeight™ 27.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med 2006 4.16
2 Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry 2010 3.42
3 The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 2006 2.46
4 Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable. Neuropsychology 2006 1.49
5 Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. J Psychiatry Neurosci 2007 0.99
6 A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacology 2010 0.94
7 A meta-analysis of profile and time-course of symptom change in acute schizophrenia treated with atypical antipsychotics. Int J Neuropsychopharmacol 2005 0.93
8 The assessment of symptom severity and functional impairment with DSM-IV axis V. Psychiatr Serv 2011 0.90
9 The hotel study: multimorbidity in a community sample living in marginal housing. Am J Psychiatry 2013 0.90
10 Personalized risk assessment of drug-related harm is associated with health outcomes. PLoS One 2013 0.85
11 Prenatal tobacco exposure in first-episode psychosis. Schizophr Res 2010 0.85
12 Predictors of starting to smoke cigarettes in patients with first episode psychosis. Schizophr Res 2009 0.84
13 A quantitative review of the profile and time course of symptom change in schizophrenia treated with clozapine. J Psychopharmacol 2012 0.81
14 Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis. Schizophr Res 2011 0.81
15 Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment. J Nerv Ment Dis 2013 0.80
16 Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients. Schizophr Res 2013 0.80
17 Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia. CNS Drugs 2007 0.80
18 Methodological considerations regarding the association of Stroop and verbal fluency performance with the symptoms of schizophrenia. Schizophr Res 2003 0.80
19 Neurocognitive profiles of marginally housed persons with comorbid substance dependence, viral infection, and psychiatric illness. J Clin Exp Neuropsychol 2014 0.80
20 Donepezil for memory dysfunction in schizophrenia. J Psychopharmacol 2002 0.77
21 Explaining individual differences in cognitive processes underlying hindsight bias. Psychon Bull Rev 2015 0.77
22 Antipsychotic medications: linking receptor antagonism to neuropsychological functioning in first episode psychosis. J Int Neuropsychol Soc 2012 0.77
23 Material-specific episodic memory associates of the psychomotor poverty syndrome in schizophrenia. Cogn Neuropsychiatry 2004 0.76
24 Cognitive-behavioral prevention of postconcussion syndrome in at-risk patients: a pilot randomized controlled trial. J Head Trauma Rehabil 2013 0.76
25 Memory interference in multiple sclerosis. J Int Neuropsychol Soc 2005 0.75
26 Effects of Exercise on Serum Triglycerides and Symptoms of Schizophrenia. J Clin Psychopharmacol 2017 0.75
27 Age differences in hindsight bias: the role of episodic memory and inhibition. Exp Aging Res 2014 0.75